Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Blinded by the Light: The Impact of Advances in Headlamp Technology on Auto Claims
Automotive headlamp technology has progressed tremendously over the past twenty years, rapidly moving beyond sealed beam and halogen headlamp assemblies. The early 2000’s saw the introduction of the first Xenon/HID systems that used pressurized gas to create a brighter and more expansive field of vision for drivers. Such technology was only available as an option on high-end luxury vehicles such as the Mercedes S Class and the BMW 7 Series.
New York Adopts Final Drug Formulary Rule
The New York Workers' Compensation Board adopted its final drug formulary rule on June 5, 2019.
Business Insurance: Addressing delays in return to work
Helen Froehlich, vice president – case management services at Genex Services LLC, discusses key challenges in getting injured employees bac
10 REASONS TO INCLUDE A PHARMACY NURSE IN YOUR WORKERS' COMPENSATION PROGRAM
A recent survey of public health experts predicted 650,000 people could die from opioid misuse within the next 10 years.¹ Public health spending is falling short, medication-assisted treatment is too rare, and the worst drug overdose epidemic in U.S. history is culling our labor force. Rising medical costs and the opioid epidemic aren’t new trends to our industry, and while there are many beneficial tools being implemented to address these issues there is also one you may be less familiar with – a pharmacy nurse.
Defining Formularies & Step Therapy Medications
HealthCare.gov defines a formulary as, a list of prescription drugs covered by a prescription drug plan offering prescription drug benefits. Typically, a “prior authorization” for coverage is needed when a medication is not listed on the formulary or requires step therapy. Management of the formulary is often maintained by a pharmacy benefit manager (PBM), such as First Script. Meaning, when a medication is not on a formulary, First Script would start the prior authorization process to get approval for payment of the medication.
From Tragedy to Triumph
Catastrophic Case ManagementMeet Charlene Ramsey, RN, BSN, CCMWhen Charlene Ramsey, RN, BSN, CCM, is